Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.470
+0.020 (1.38%)
At close: Mar 3, 2026, 4:00 PM EST
1.340
-0.130 (-8.84%)
Pre-market: Mar 4, 2026, 4:39 AM EST
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $7.39 million as of March 4, 2026. Its market cap has decreased by -93.21% in one year.
Market Cap
7.39M
Enterprise Value
14.06M
1-Year Change
-93.21%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $7.39M, a decrease of -97.89%. That is a compound annual growth rate of -62.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 7.29M | -48.61% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 7.71M |
| PharmaCyte Biotech | 7.56M |
| Evogene | 7.44M |
| Alzamend Neuro | 7.42M |
| Kiora Pharmaceuticals | 7.41M |
| CollPlant Biotechnologies | 7.41M |
| Addex Therapeutics | 7.08M |
| Mustang Bio | 7.08M |